Page 43 - fbkCardioDiabetes_2017

Cardio Diabetes Medicine 2017 19

Let us adopt advances in Medicine to Prevent &
Control Diabetes in Men & Women.
In Utero Intervention is a key Message.
References:-

1. Qazi MU, Malik S. Diabetes and Cardiovascular Disease: Insights from the
Framingham Heart Study. Global heart. 2013 Mar 31;8(1):43-8.
2. Friedberg CK. Diseases of the heart. WB Saunders Company; Philadelphia:
1949. p. 939.
3. Kannel WB, McGee DL. Diabetes and Cardiovascular Disease. JAMA.
1979;241:2035–2038
4. Kannel WB, McGee DL. Diabetes and Cardiovascular Disease. JAMA.
1979;241:2035–2038
5. Fox CS, Pencina MJ, Meigs JB, et al. Trends in the incidence of type 2
diabetes mellitus from the 1970s to the 1990s: the Framingham Heart
Study. Circulation. 2006;113:2914–2918
6. Fox CS, Coady S, Sorlie PD, et al. Increasing cardiovascular disease bur-
den due to diabetes mellitus: the Framingham Heart Study. Circulation.
Implication:- 2007;115:1544–1550
* Diet and Lifestyle to target Inutero Nutrition and 7. Preis SR, Pencina MJ, Hwang SJ, et al. Trends in cardiovascular disease risk
Growth factors in individuals with and without diabetes mellitus in the Framingham
Heart Study, 1950–2005. Circulation. 2009;119(13):1728–1735. 2009a
* Gene Therapy 8. Haffner SM, Lehto S, Rönnemaa T, et al. Mortality from coronary heart
Conclusion:- disease in subjects with type 2 diabetes and in nondiabetic subjects with
and without prior myocardial infarction. N Engl J Med. 1998;339:229–34.
Cardiodiabetes – is a joint approach the way forward? 9. Whiteley L, Hole D, Padmanabhan S, et al. Should diabetes be considered
a coronary heart disease risk equivalent? Diabetes Care. 2005;28:1588–
Diabetes and serious cardiovascular disease 1593
are frequently observed together, the term
‘cardiodiabetes’ is increasingly applied to describe 10. Meigs JB, Jacques PF, Selhub J, et al. Fasting plasma homocysteine levels
in the insulin resistance syndrome. Diabetes Care. 2001;24(8):1403–1410
the convergence of these conditions.
11. Truett J, Cornfield J, Kannel W. A multivariate analysis of the risk of
The European Society of Cardiology – European coronary heart disease in Framingham. J Chronic Dis. 1967;20:511–524
Association for the Study of Diabetes (ESC-EASD) 12. Buse JB, Ginsberg HN, Bakris G. Primary prevention of cardiovascular dis-
Task Force guidelines of 2007 acknowledge eases in people with diabetes mellitus. Diabetes Care. 2007;30:162–172
the inter-relationship between diabetes and 13. Gupta R, Mohan I, Narula J. Trends in coronary heart disease epidemiology
cardiovascular disease and call for an early, in India. Annals of global health. 2016 Apr 30;82(2):307-15.
multidisciplinary approach to the recognition and 14. Coronary Angioplasty in Diabetic Patients.Current and Future Perspective
intensive management of all cardiodiabetes risk Joaquin J Alonso a,Juan M Duran a, Federico Gimeno a, Benigno Ramos
factors. The Key to Cardiodabetology is a focuson a, Ana Serrador a, Franscisco Fernandez- Aviles
a Multidisciplinary approach to ensure that the 15. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ,Mountz
numerous Global ASCVD Risk factors. The evidence JD. Protection from Fas-mediated apoptosis by a soluble form of the Fas
17
that Diabetes is a key factor in cardiovascular disease molecule.Science. 1994;263:1759–1762
is also highlighted by the National Institute for Health 16. http://medicalfuturist.com/the-most-exciting-medical-technolo-
and Clinical Excellence (NICE) clinical guidelines gies-of-2017
on lipid modification and type 2 diabetes, which 17. The Emergence of Cardiodiabetology, paul D.Rosenblit ,Norman E.Lepor c
a
recommend treatment of serum lipids in patients with and Nathan D.Wong cardiovascular Endocrinology, 2017,6:3-7
b
type 2 diabetes mellitus and those with established 18. National Institute for Health and Clinical Excellence. Clinical Guideline 67.
cardiovascular disease (CVD). Lipid Modification. Cardiovascular risk assessment and the modification
of blood lipids for the primary and secondary prevention of cardiovascular
‘Prevention of cardiovascular disease must focus disease. May 2008
equally on patients with established atherosclerotic 19. PC.Manoria, cardiodiabetology The Inutero connection, vol XII(Part-I),1998
disease and on people with Diabetes’ 18
20. Sam.G.P.Moses , G.Anantha subramaniam,T.K.Ramana kumar,Manual on
India is the Diabetes Capital of the World. Cardiodiabetology,1991

India is the Cardiac Disease Capital of the World.

Cardio Diabetes Medicine